News

CQDM Partners with MaRS Innovation, Ontario Brain Institute and Ontario Centres of Excellence to Launch Life Sciences Funding Program Within Ontario-Québec Corridor

BOSTON, MA, June 18, 2012 — Together with key partners from Ontario, The Québec Consortium for Drug Discovery (CQDM) is creating a new initiative to fund collaborative life sciences research projects between the two provinces.

A French version of this release is available via CQDM’s website.

This initiative is the first notable and concrete realization of the Ontario-Québec Life Sciences Corridor, announced at the 2011 BIO International Convention. It builds upon two previous pilot projects and existing strengths within the two provinces to increase innovation, productivity, investment and job creation.

Encycle Therapeutics Launches Ground-Breaking Chemistry Platform

Platform for cyclizing peptides promises to increase efficiency of early-stage drug discovery

BOSTON, June 18, 2012 – Encycle Therapeutics, a MaRS Innovation spin-off company, has created a ground-breaking chemistry platform for cyclizing peptides that promises to increase the efficiency of the early-stage drug discovery process.

Peptides have long been sought after as therapeutics due to their high specificity — they can hit specific cellular targets, especially complex protein-protein interaction targets implicated in cancer, cardiovascular disease and metabolic disorders.

National Post, Financial Post spotlight Flybits’ expansion to Tech City, London (U. K.)

June 18, 2012
Susanne Staer
Flybits

The Financial Post and the National Post each ran a feature article June 18, 2012 concerning the United Kingdom’s efforts to attract Canadian-based technology start-ups seeking entrance into European markets.

Flybits, a Mars Innovation spin-off company based on the research of Ryerson University professor Hossein Rahnama, was among those profiled.

The Accelerator Gazette Interviews Dr. Hossein Rahnama About Student Entrepreneurship

June 14, 2012
Susanne Staer
Flybits

Ryerson University, one of MaRS Innovation’s 16 member institutions, has created the Digital Media Zone (DMZ) to give student entrepreneurs and researchers — or anyone connected with a great idea connected to their campus — the space they need to grow their ideas.

Dr. Hossein Rahnama, the DMZ’s research director and a Ryerson University professor, was interviewed this week by The Accelerator Gazette about Ryerson’s approach to accelerating and incubating technologies.

OtoSim Inc. Makes a Sound Pitch on BNN

OtoSim listens to the Verdict on BNN's The Pitch — Louis Hui (far left) listens to the panel’s comments on BNN’s The Pitch.

OtoSim Inc., a MaRS Innovation spin-off company, made its debut on Business News Network’s The Pitchon June 1, 2012.

Louis Hui, OtoSim’s business development manager, had 90 seconds to pitch OtoSim™ — an integrated educational system that dynamically and interactively teaches how to accurately diagnose ear diseases — to The Pitch’s panel of financiers and experts.

Flybits CEO Presents Mobile Technology Platform to the Prince of Wales

May 23, 2012
Susanne Staer
Flybits

TORONTO (May 22, 2012) — Flybits CEO and Founder Hossein Rahnama was among the entrepreneurs of Ryerson University’s Digital Media Zone (DMZ) to meet the Prince of Wales and demonstrate his cloud-based and context-aware software solution.

Prince Charles, Hossein Rahnama and Dalton McGuinty — Flybits CEO Hossein Rahnama (left) demonstrates his mobile technology for His Royal Highness Prince Charles and Premier Dalton McGuinty (right)

Flybits Inc., a Mars Innovation spin-off company from Ryerson University where Rahanama is a professor and research director of the DMZ, has developed an innovative, context-aware software as a service framework called FARE (Flybits Activity Recognition Engine).

It allows mobile application developers to rapidly build intelligent mobile applications that address the needs of multiple vertical markets without excessive infrastructure requirements.

OtoSim Inc. to Appear on BNN’s The Pitch

OtoSim Inc., a MaRS Innovation spin-off company, is taping an appearance on Business News Network’s The Pitch on May 22, 2012.

Louis Hui, OtoSim’s business development manager, will have 90 seconds to pitch OtoSim™ — an integrated educational system that dynamically and interactively teaches how to accurately diagnose ear diseases — to The Pitch’s panel of financiers and experts.

ScarX Therapeutics Featured on Front Page of the Globe and Mail

MaRS Innovation’s ScarX Therapeutics, a strategic partnership with The Hospital for Sick Children (SickKids) and NovoTek Therapeutics Inc. (NovoTek), was featured on the front page of the Globe and Mail on May 7, 2010.

Read the article on Globe and Mail.com (note that depending on when you’re accessing this page, the Globe‘s content may be subject to a pay wall).

MaRS Innovation Forms Strategic Drug-Development Partnership with NovoTek Therapeutics Inc. in China

MaRS Innovation (MI), The Hospital for Sick Children (SickKids) and NovoTek Therapeutics Inc. (NovoTek) have announced a strategic partnership to co‐develop, and bring to the Chinese market, a novel therapeutic cream aimed at reducing scar formation post surgery.

This project was covered in The Globe and Mail on May 7, 2012.

ApneaDX Inc: A Medical Device to Accurately Diagnose Sleep Apnea at Home

April 27, 2012
Susanne Staer
BresoTec Inc.

MaRS Innovation and the University Health Network‘s Toronto Rehabilitation Institute have collaborated to bring a new technology to market that accurately diagnoses sleep apnea at the patient’s home.

Sleep apnea is a medical disorder that is gaining increasing recognition as a major health issue. It is estimated that six to eight per cent of the world’s population suffer from the disease, but 85 per cent are undiagnosed.

Undiagnosed sleep apnea is estimated to cause $3.4 billion in additional medical costs in the US.

CQDM Partners with MaRS Innovation, Ontario Brain Institute and Ontario Centres of Excellence to Launch Life Sciences Funding Program Within Ontario-Québec Corridor

Encycle Therapeutics Launches Ground-Breaking Chemistry Platform

National Post, Financial Post spotlight Flybits’ expansion to Tech City, London (U. K.)

The Accelerator Gazette Interviews Dr. Hossein Rahnama About Student Entrepreneurship

OtoSim Inc. Makes a Sound Pitch on BNN

OtoSim Inc. to Appear on BNN’s The Pitch

ScarX Therapeutics Featured on Front Page of the Globe and Mail

MaRS Innovation Forms Strategic Drug-Development Partnership with NovoTek Therapeutics Inc. in China

ApneaDX Inc: A Medical Device to Accurately Diagnose Sleep Apnea at Home

Quick Links

Contact Us